Viewing StudyNCT00383929



Ignite Creation Date: 2024-05-05 @ 5:05 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00383929
Status: COMPLETED
Last Update Posted: 2008-03-20
First Post: 2006-10-03

Brief Title: Antihypertensive Efficacy and Safety of CandesartanHCT 32125 and 3225 mg in Comparison With Candesartan 32 mg
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: D2456C00001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators